发明名称 Topical formulation
摘要 The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.
申请公布号 US8748467(B2) 申请公布日期 2014.06.10
申请号 US20080524421 申请日期 2008.01.22
申请人 Bayer Intellectual Property GmbH 发明人 Nanjan Karthigeyan;Al Alawi Fadil;Chambers Paul;Hill Kate
分类号 A01N43/50;A61K31/415 主分类号 A01N43/50
代理机构 代理人
主权项 1. A composition formulated for transdermal administration to a cat consisting of methimazole or a prodrug thereof as the active agent, and further comprising; 22% w/w polyethylene glycol 4000; 9% w/w oleic acid; 9% w/w N-methyl-2-pyrrolidone or D-limonene; and propylene glycol as the non-active agents.
地址 Monheim DE